Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 30.74K / 565.21K |
Day Range | - - - |
52 Wk Range | 0.63 - 1.76 |
Market Cap | $39.93M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 79 |
Short Interest | 0.01% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Achilles Therapeutics (NASDAQ:ACHL) through any online brokerage.
Other companies in Achilles Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA) and OncoCyte (NASDAQ:OCX).
Achilles Therapeutics has a consensus price target of $2.83.
The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $0.9351 last updated September 20, 2024 at 5:53 AM EDT.
There are no upcoming dividends for Achilles Therapeutics.
Achilles Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Achilles Therapeutics.
Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.